ZÜRICH, Switzerland — July 4, 2025 — The new edition of the International Production Cost Comparison (IPCC) from ITMF has ...

Weeks into his new role as president and CEO of Bryn Mawr, Pa.-based Main Line Health, Edward Jimenez told Becker’s the five-hospital system — with more than 13,000 employees — is taking steps to stay ...

This paper presents an update on recently introduced low-cost CVD reactor for graphene synthesis in metamaterial research. Apart from previously reported synthesis of single-layer graphene, it has ...

GameStop Corp. GME delivered a notable improvement in its fiscal first-quarter 2025 results, driven largely by disciplined cost management and improved operational efficiency. The company slashed ...

Scientists in Switzerland have conducted techno-economic analysis of perovskite solar module manufacturing costs in terms of ...

Even with the stock's resounding three-year gain, its valuation has decreased when looking at price-to-free cash flow (P/FCF) ...

Since taking charge of Intel in March, new CEO Lip‑Bu Tan has wasted no time tackling costs and hunting for fresh growth ...

Making it easier to build more, smaller houses would bring down home prices and help bring back the starter home. Part 2 in a series shows how three cities in North Carolina and Oregon have done just ...

Background The KEYNOTE-966 study demonstrated that pembrolizumab combined with chemotherapy is more effective than chemotherapy alone as first-line treatment for patients with advanced biliary tract ...

How AI-driven personalization, knowledge graphs and a two-sided marketplace are creating a new business model for the 75-year-old retailer.

Freeport-McMoRan reported strong Q1, lower net cash costs, and steady revenue growth projections support the investment case.

Objective Neratinib plus capecitabine (Ner+Cap) were proved to be clinically beneficial as a third-line treatment for women with human epidermal growth factor receptor-2 (HER2) positive metastatic ...